Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Study of the Vesicular Acetylcholine Transporter (Vacht)

Study of the Vesicular Acetylcholine Transporter (Vacht)

Rahman MD Rashidur

Paperback

Medical Reference

Currently unavailable to order

ISBN10: 3659376507
ISBN13: 9783659376504
Publisher: Lap Lambert Academic Pub
Published: Apr 29 2013
Pages: 52
Weight: 0.20
Height: 0.12 Width: 6.00 Depth: 9.00
Language: English
Cognitive impairment is a hallmark of many neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease and others. Today AD is the most common cause of dementia. This is a disease causing great sufferings to the patient and their relatives and is also an increasing healthcare problem with economical as well as social consequences. AD is a very high cost management disease increasing in an alarming rate in USA. It is very important to diagnose and investigate AD in the early stage that can be helpful both for the patient and for the family. As Acetylcholine (ACh)deficiency is seen in AD, quantifying VAChT (Vesicular Acetylcholine Transporter) levels in the cholinergic nerve terminal predict the ACh levels and may subsequently help in diagnosing AD. This book describes in vitro method to develop a selective and specific PET tracer with suitable characteristics that allow the in vivo study of VAChT levels could be used as a biomarker for studying changes in cholinergic functions in both animals and humans. This book should be especially useful to students, researchers and academicians who are involved in radio tracer development work for diagnosing of AD.

Also in

Medical Reference

View All